Corporate News

Notice of Final Results & Investor Presentation

27 July 2023

Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health & Nutrition products, confirms it will issue its final results for the year ended 31 March 2023 on Thursday 3 August 2023.

Analyst briefing

A briefing for analysts will take place in London on Thursday 3 August 2023 at 9:30 BST. To register and for more details please contact Walbrook PR on [email protected].

Investor presentation

Jag Grewal, CEO and Chris Lea, CFO will provide a live presentation relating to the Final Results via the Investor Meet Company platform on Thursday 3 August 2023 at 16:30 BST.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet Omega Diagnostics Group plc via:  

Investors who already follow Omega Diagnostics Group plc on the Investor Meet Company platform will automatically be invited.



Omega Diagnostics Group PLC                 

Jag Grewal, Chief Executive Officer                            

via Walbrook PR

Chris Lea, Chief Financial Officer

finnCap Ltd                                              

Tel: 020 7220 0500

Geoff Nash/Edward Whiley/George Dollemore (Corporate Finance)

Alice Lane/Charlotte Sutcliffe (ECM)

Walbrook PR Limited

Tel: 020 7933 8780 or [email protected]

Lianne Applegarth

Mob: 07584 391 303

Sam Allen

Mob: 07502 558 258


About Omega Diagnostics Group PLC

Omega (AIM: ODX) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.

Sign up for Investor Alerts